SBSelma B. Belfakir

Selma B. Belfakir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Selma B. Belfakir has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nanobody-based lateral flow assays for the detection of α-bungarotoxin in Bungarus snake venoms

    by Suthimon Thumtecho, Selma B. Belfakir, Tenna V. K. Christensen, Esperanza Rivera-De-Torre, Nick J. Burlet, Anne Ljungars, Georgina M. S. Ross, Andreas H. Laustsen

    Accurate snake identification is critical for effective antivenom treatment following snakebite envenoming, but remains a major diagnostic challenge. Here, we developed a prototype lateral flow immunoassay (LFIA) designed to distinguish krait ( Bungarus ) from cobra ( Naja ) envenoming in Southeast Asia. To enhance point-of-care utility, the assay employs variable domains of heavy-chain-only antibodies (V H Hs). The V H Hs target α-bungarotoxin (α-BuTx), a neurotoxin unique to Bungarus , with negative selection strategies to minimize cross-reactivity with α-cobratoxin in Naja venom. Our prototype LFIA detected α-BuTx with a visual limit of detection of 0.5–5 ng/mL in running buffer and spiked urine and serum samples. Additionally, the assay detected Bungarus whole venom at 50–500 ng/mL in running buffer. No cross-reactivity with Naja venom was observed at clinically relevant concentrations, with signals detected only at supraphysiological concentrations (≥50,000 ng/mL). These results support the feasibility of using V H H-based LFIAs for guiding timely, targeted antivenom administration in resource-limited settings.

  • Open Access

    Controlled immobilization of single-domain antibodies using cellulose-binding modules for AB 5 -type toxin detection in paper-based assays

    by Selma B. Belfakir, Jonas A. Jürgensen, Marcus Petersson, Max Stæhr Wraae, Patrick Munk, Suthimon Thumtecho, Mateus G. Masteghin, Anne Ljungars, Andreas H. Laustsen, Sandra W. Thrane, et al.

    A single-domain antibody (VHH)-based sandwich-format lateral flow assay was developed for the detection of cholera toxin from V. cholerae and heat-labile enterotoxin from enterotoxigenic E. coli in human fecal and environmental water samples.


  • Open Access

    Leveraging cellulose-binding domains to orient and immobilize single-domain antibodies onto paper-based immunoassays

    by Selma B. Belfakir, Everardo R. Rodriguez-Rodriguez, Sandra W. Thrane, Anne Ljungars, Winnie E. Svendsen, Andreas H. Laustsen, Georgina M.S. Ross


  • Open Access

    Cellulose immobilization strategies for paper-based immunoassays

    by Selma B. Belfakir, Winnie E. Svendsen, Andreas H. Laustsen, Georgina M.S. Ross


  • Open Access

    Multiplex lateral flow assay development for snake venom detection in biological matrices

    by Cecilie Knudsen, Selma B. Belfakir, Pelle Degnegaard, Jonas A. Jürgensen, Aleksander M. Haack, Rasmus U. W. Friis, Søren H. Dam, Andreas H. Laustsen, Georgina M. S. Ross

    Bothrops and Lachesis are two of Brazil’s medically most relevant snake genera, causing tens of thousands of bites annually. Fortunately, Brazil has good accessibility to high-quality antivenoms at the genus and inter-genus level, enabling the treatment of many of these envenomings. However, the optimal use of these treatments requires that the snake species responsible for the bite is determined. Currently, physicians use a syndromic approach to diagnose snakebite, which can be difficult for medical personnel with limited training in clinical snakebite management. In this work, we have developed a novel monoclonal antibody-based multiplex lateral flow assay for differentiating Bothrops and Lachesis venoms within 15 min. The test can be read by the naked eye or (semi)-quantitatively by a smartphone supported by a 3D-printed attachment for controlling lighting conditions. The LFA can detect Bothrops and Lachesis venoms in spiked plasma and urine matrices at concentrations spanning six orders of magnitude. The LFA has detection limits of 10–50 ng/mL in spiked plasma and urine, and 50–500 ng/mL in spiked sera, for B. atrox and L. muta venoms. This test could potentially support medical personnel in correctly diagnosing snakebite envenomings at the point-of-care in Brazil, which may help improve patient outcomes and save lives.


  • Open Access

    A comparative study of the performance of E. coli and K. phaffii for expressing α-cobratoxin

    by Anna Damsbo, Charlotte Rimbault, Nick J. Burlet, Anneline Vlamynck, Ida Bisbo, Selma B. Belfakir, Andreas H. Laustsen, Esperanza Rivera-De-Torre


  • Open Access

    Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms

    by Cecilie Knudsen, Jonas A. Jürgensen, Pelle D. Knudsen, Irina Oganesyan, Julian A. Harrison, Søren H. Dam, Aleksander M. Haack, Rasmus U.W. Friis, Lars Vitved, Selma B. Belfakir, et al.


  • Open Access

    Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms

    by Cecilie Knudsen, Jonas A. Jürgensen, Pelle D. Knudsen, Irina Oganesyan, Julian A. Harrison, Søren H. Dam, Aleksander M. Haack, Rasmus U. W. Friis, Selma B. Belfakir, Georgina M. S. Ross, et al.

    Background: Brazil is home to a multitude of venomous snakes, perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp . are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice in antivenom that is administered depends not only on its availability and how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of a photo of the snake or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has. Results: In this paper, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp . The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp . specific antibody sandwich pairs. The sandwich pairs were used to develop a prototype LFA that was able to detect venom from several different Bothrops spp . The limit of detection (LoD) of the prototype was evaluated using Brazilian B. atrox whole venom and was determined to be 8.0 ng/mL in spiked serum samples and 9.5 ng/mL in spiked urine samples, when using a portable reader, and < 25 ng/mL in spiked buffer when reading by eye. Significance: The work presented here serves as a proof of concept of a genus-specific venom detection kit, which could support physicians in diagnosing Bothrops envenomings. Although further optimization and testing is needed before the LFA can find clinical use, such a device could aid in decentralizing antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.